Equities analysts expect Teva Pharmaceutical Industries Limited (NYSE:TEVA) to announce $5.63 billion in sales for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Teva Pharmaceutical Industries Limited’s earnings, with the lowest sales estimate coming in at $5.58 billion and the highest estimate coming in at $5.72 billion. Teva Pharmaceutical Industries […]
